NDC 49702-238 - Cabenuva
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 49702-238
- Package NDCs from labels
- 49702-238-01, 49702-238-64, 49702-238-03, 49702-238-61
- Manufacturer
- ViiV Healthcare Company | Glaxo Wellcome Manufacturing Pte. Ltd | Janssen Pharmaceutica NV
- Effective date
- 2025-11-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cabenuva - ViiV Healthcare Company | Glaxo Wellcome Manufacturing Pte. Ltd | Janssen Pharmaceutica NV | ViiV Healthcare Company | Glaxo Wellcome Manufacturing Pte. Ltd | Janssen Pharmaceutica NV | 2025-11-26 | HUMAN PRESCRIPTION DRUG LABEL |
| Apretude - ViiV Healthcare Company | ViiV Healthcare Company | 2025-04-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49702-238-01 | Cabenuva | 3 mL in 1 VIAL | INJECTION, SUSPENSION, EXTENDED | 1 mL | 200 mg in 1mL | 16 |
| 49702-238-64 | Cabenuva | 3 mL in 1 VIAL | INJECTION, SUSPENSION, EXTENDED | 1 mL | 200 mg in 1mL | 16 |
| 49702-238-03 | Apretude | 3 mL in 1 VIAL | INJECTION, SUSPENSION, EXTENDED | 3 mL | 200 mg in 1mL | 8 |
| 49702-238-61 | Apretude | 3 mL in 1 VIAL | INJECTION, SUSPENSION, EXTENDED | 3 mL | 200 mg in 1mL | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 49702-238 | CABENUVA (CABOTEGRAVIR AND RILPIVIRINE) KIT [VIIV HEALTHCARE COMPANY] | 14 | Unmatched | 20250416_1698baf3-f895-4c42-a1b1-e9ee3f20da36.zip |
| 49702-238 | APRETUDE (CABOTEGRAVIR) KIT [VIIV HEALTHCARE COMPANY] | 8 | Unmatched | 20250419_4338428e-43d4-4e02-ac9d-bd98e738a7da.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| leader clearlax | POLYETHYLENE GLYCOL 3350 | Cardinal Health 110, LLC. dba Leader | 812c59b0-e7ce-4c7a-91ed-e74b7b1b84be | 2026-09-22 | Warnings | G2M7P15E5P |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | L.N.K. International, Inc. | bbc11078-73f7-4d27-b0d3-4d4ae5dae240 | 2026-09-10 | Warnings | G2M7P15E5P |
| Dextrose | DEXTROSE MONOHYDRATE | Henry Schein, Inc. | 8cf6943f-16e8-4521-863c-09bb0b55e2a9 | 2026-09-09 | Warnings, Adverse reactions | LX22YL083G |
| CLEARLAX | POLYETHYLENE GLYCOL 3350 | Amazon.com Services LLC | 7ed915ec-7e99-4e0e-aca0-20718987a88c | 2026-09-08 | Warnings | G2M7P15E5P |
| purelax | POLYETHYLENE GLYCOL 3350 | CVS Pharmacy | fc3b6006-a75a-41b3-9f0b-a3152df1363f | 2026-09-04 | Warnings | G2M7P15E5P |
| basic care clearlax | POLYETHYLENE GLYCOL 3350 | Amazon.com Services LLC | 1ccb8604-34f6-4e1e-beed-eb81d6aa7aef | 2026-09-03 | Warnings | G2M7P15E5P |
| purelax | POLYETHYLENE GLYCOL 3350 | CVS Pharmacy | 006a9eca-400f-47f5-bee5-facf7034043e | 2026-09-02 | Warnings | G2M7P15E5P |
| Kroger | POLYETHYLENE GLYCOL 3350 | KROGER COMPANY | c56271ff-703a-40c4-840f-1962798c9e42 | 2026-09-02 | Warnings | G2M7P15E5P |
| gentle lax | POLYETHYLENE GLYCOL 3350 | Kroger Company | 0d820dcc-440a-4036-86e9-fdb30cac9573 | 2026-09-01 | Warnings | G2M7P15E5P |
| CLEARLAX | POLYETHYLENE GLYCOL 3350 | Amazon.com Services LLC | bd33463b-eb1a-41ed-92d1-f50d0923eb3b | 2026-08-31 | Warnings | G2M7P15E5P |
| Dextrose | DEXTROSE MONOHYDRATE | REMEDYREPACK INC. | b8b77421-d687-45aa-82f6-d49bce644c10 | 2026-08-31 | Warnings, Adverse reactions | LX22YL083G |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | Cardinal Health 107, LLC | 4d524ace-9de5-4f62-9263-7cd88a36b67c | 2026-08-28 | Warnings | G2M7P15E5P |
| PEG3350 | POLYETHYLENE GLYCOL 3350 | Major Pharmaceuticals | 161629f6-6193-4712-bba7-7d5b174a9338 | 2026-08-28 | Warnings | G2M7P15E5P |
| Mix-In Laxative Packets | POLYETHYLENE GLYCOL 3350 | Wal-Mart Stores Inc | 0347c934-1e85-4f8d-8d35-bb07f16810ad | 2026-08-27 | Warnings | G2M7P15E5P |
| KUGIG ALOE FOAMING INTIMATE WASH | INTIMATE CLEANSING FOAM | Hong Kong KangXing Centennial Management Limited | 59f4d398-1186-a168-e063-6294a90ab44b | 2026-08-26 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | REMEDYREPACK INC. | 5dd5d148-6e23-41de-bff5-551b2aea9598 | 2026-08-24 | Warnings, Adverse reactions | 059QF0KO0R |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | df18a603-ca12-4b26-83b5-9dd07b6453ab | 2026-08-18 | Warnings, Adverse reactions | LX22YL083G |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | bbc5b820-4973-11e2-a192-0002a5d5c51b | 2026-08-18 | Warnings, Adverse reactions | LX22YL083G |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | c29bdfa0-4976-11e2-939b-0002a5d5c51b | 2026-08-18 | Warnings, Adverse reactions | LX22YL083G |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | 515dcee0-3e34-11e2-a25f-0800200c9a66 | 2026-08-18 | Warnings, Adverse reactions | LX22YL083G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.